Pharmacodynamic Analysis of Changes in Reticulocyte Subtype Distribution in Phlebotomy-induced Stress Erythropoiesis

Overview

Journal J Pharmacokinet Pharmacodyn

Publisher Springer

Specialty Pharmacology

Date 2005 Nov 15

PMID 16284920

Citations 14

Authors

Nidal H Al-Huniti

John A Widness

Robert L Schmidt

Peter Veng-Pedersen

Affiliations

Soon will be listed here.

Abstract

Changes in the reticulocyte subtype distribution (high, medium and low reticulocytes count (HR, MR, LR)) measured by flow cytometry following phlebotomy-induced stress erythropoiesis (abruptly dropping hemoglobin to 3-4 g/dl over 4-5 hr) and the pharmacodynamic (PD) relationship to the stimulated erythropoietin (EPO) was investigated in sheep. A PD model was developed that describes the relationship between EPO and the reticulocyte maturity distribution fractions (r=0.95+/-0.02, mean +/- SD). The lag-time between EPO activation of erythroid progenitor cells and the subsequent increase in the least mature HR fraction in the peripheral circulation was 0.72 +/- 0.08 days. The mean transition times (in days) for all three reticulocyte fractions changed at baseline from, T(HR) : 0.09 +/- 0.06, T(MR) : 0.06 +/- 0.04, and T(LR) : 0.46 +/- 0.24 to T(HR) : 0.13 +/- 0.08, T(MR) : 0.29 +/- 0.15, and T(LR) : 2.3 +/- 0.24 under stress erythropoiesis. The total mean residence time for a reticulocyte in the peripheral circulation, T(total) (T(HR) + T(MR) + T(LR)), increased from 0.60 +/- 0.33 days under basal to 2.8 +/- 0.09 days during stress erythropoiesis. The statistically significant increase observed for T(LR) and T(total) supports the hypothesis that stress erythropoiesis perturbs the mean reticulocyte transition times. A correlation analysis between various new, proposed metrics involving the HR, MR and LR fractions and the total reticulocyte count, with the latter indicative of stress erythropoiesis at higher total counts, revealed a highly significant correlation indicating these new metrics may be a valuable adjunct to the reticulocyte maturation index (RMI) and the immature reticulocyte fractions index (IRF) previously used in assessing erythropoietic activity in response to anemia.

Citing Articles

Impaired Terminal Erythroid Maturation in β-Thalassemia/HbE Patients with Different Clinical Severity.

Suriyun T, Winichagoon P, Fucharoen S, Sripichai O J Clin Med. 2022; 11(7).

PMID: 35407362 PMC: 8999960. DOI: 10.3390/jcm11071755.

Neocytolysis: How to Get Rid of the Extra Erythrocytes Formed by Stress Erythropoiesis Upon Descent From High Altitude.

Mairbaurl H Front Physiol. 2018; 9:345.

PMID: 29674976 PMC: 5896414. DOI: 10.3389/fphys.2018.00345.

Models for the red blood cell lifespan.

Shrestha R, Horowitz J, Hollot C, Germain M, Widness J, Mock D J Pharmacokinet Pharmacodyn. 2016; 43(3):259-74.

PMID: 27039311 PMC: 4887310. DOI: 10.1007/s10928-016-9470-4.

Decreased stability of erythroblastic islands in integrin β3-deficient mice.

Wang Z, Vogel O, Kuhn G, Gassmann M, Vogel J Physiol Rep. 2013; 1(2):e00018.

PMID: 24303107 PMC: 3831914. DOI: 10.1002/phy2.18.

Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep.

Saleh M, Widness J, Veng-Pedersen P Biopharm Drug Dispos. 2011; 32(3):131-9.

PMID: 21456051 PMC: 3657587. DOI: 10.1002/bdd.743.

References

Pradella M, Cavill I, DOnofrio G . Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting. Clin Lab Haematol. 1996; 18 Suppl 1:35-7. View

Pedersen P . Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm. 1977; 5(5):513-31. DOI: 10.1007/BF01061732. View

Ramakrishnan R, Cheung W, Wacholtz M, Minton N, Jusko W . Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol. 2004; 44(9):991-1002. DOI: 10.1177/0091270004268411. View

Al-Huniti N, Widness J, Schmidt R, Veng-Pedersen P . Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia. J Pharmacol Exp Ther. 2004; 310(1):202-8. DOI: 10.1124/jpet.104.066027. View

Shimada A . The maturation of reticulocytes. II. Life-span of red cells originating from stress reticulocytes. Acta Med Okayama. 1975; 29(4):283-9. View

. Flow cytometric reticulocyte quantification in the evaluation of hematologic recovery. Spanish Multicentric Study Group for Hematopoietic Recovery. Eur J Haematol. 1994; 53(5):293-7. View

Noronha J, De Souza C, Vigorito A, Aranha F, Zulli R, Miranda E . Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation. Clin Lab Haematol. 2003; 25(1):47-54. DOI: 10.1046/j.1365-2257.2003.00486.x. View

Fisher J . Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003; 228(1):1-14. DOI: 10.1177/153537020322800101. View

Sowade O, Sowade B, Brilla K, Franke W, Stephan P, Gross J . Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients. Am J Hematol. 1997; 55(2):89-96. DOI: 10.1002/(sici)1096-8652(199706)55:2<89::aid-ajh7>3.0.co;2-z. View

10.

Torres Gomez A, Casano J, Sanchez J, Madrigal E, Blanco F, Alvarez M . Utility of reticulocyte maturation parameters in the differential diagnosis of macrocytic anemias. Clin Lab Haematol. 2003; 25(5):283-8. DOI: 10.1046/j.1365-2257.2003.00536.x. View

11.

Jelkmann W . Erythropoietin: structure, control of production, and function. Physiol Rev. 1992; 72(2):449-89. DOI: 10.1152/physrev.1992.72.2.449. View

12.

Brugnara C . Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci. 2000; 37(2):93-130. DOI: 10.1080/10408360091174196. View

13.

Fisher J . Erythropoietin: physiologic and pharmacologic aspects. Proc Soc Exp Biol Med. 1997; 216(3):358-69. DOI: 10.3181/00379727-216-44183. View

14.

Veng-Pedersen P, Chapel S, Schmidt R, Al-Huniti N, Cook R, Widness J . An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia. Pharm Res. 2002; 19(11):1630-5. DOI: 10.1023/a:1020797110836. View

15.

REYNAFARJE C, Ramos J, FAURA J, VILLAVICENCIO D . HUMORAL CONTROL OF ERYTHROPOIETIC ACTIVITY IN MAN DURING AND AFTER ALTITUDE EXPOSURE. Proc Soc Exp Biol Med. 1964; 116:649-50. DOI: 10.3181/00379727-116-29331. View

16.

Davis B, Bigelow N . Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index. Arch Pathol Lab Med. 1989; 113(6):684-9. View

17.

Brockmoller J, Kochling J, Weber W, Looby M, Roots I, Neumayer H . The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients. Br J Clin Pharmacol. 1992; 34(6):499-508. PMC: 1381451. View

18.

ABBRECHT P, Littell J . Plasma erythropoietin in men and mice during acclimatization to different altitudes. J Appl Physiol. 1972; 32(1):54-8. DOI: 10.1152/jappl.1972.32.1.54. View

19.

Lee L, Chen C, Chiu L . Thiazole orange: a new dye for reticulocyte analysis. Cytometry. 1986; 7(6):508-17. DOI: 10.1002/cyto.990070603. View

20.

Dubner D, Perez M, Barboza M, Sorrentino M, Robinson A, Gisone P . [Evolutionary and bone marrow recovery indicators in bone marrow transplantation after total body irradiation]. Medicina (B Aires). 2003; 62(6):555-61. View